Regular physical activity & a healthy diet are 2 of the most important modifiable factors in long-term health for #CancerSurvivors. 🍅🥦⛹️‍♀️🏊‍♂️ Share this #infographic with your patients & access the latest recommendations from American Cancer Society here: bit.ly/ACSnutrition-a…

American Cancer Society joins Commission on Cancer in their 100 year celebration of bringing quality cancer care to patients and their families. Kathy Goss AmerCancerCMSO American Cancer Society

Terrific work returning people to cancer screening presented by Rachel Joung at the Cancer Programs meeting today.Proud of collaboration between American College of Surgeons Cancer Programs and American Cancer Society. Leveraging our strengths to amplify successes & generate metrics for next steps

Great to see FDA approval of the 1st targeted radiotherapy for advanced #ProstateCancer. ACS Research is committed to reducing PrCa burden, funding 65 PrCa grants ($26.3M) at 52 different institutions in the past 5 yrs with 18 focused on PrCa metastasis fda.gov/drugs/resource…

Great news for B-cell lymphoma patients! American Cancer Society and ACS Research supports research in B-cell lymphoma and CAR T-cell treatment to help develop more effective therapies. fda.gov/drugs/resource…

Congratulations to Dr. Sue Hankinson for winning the AACR-American Cancer Society award for Research Excellence in Cancer Epidemiology and Prevention AACR #AACR2022 AmerCancerCMSO American Cancer Society

Great to see Dr Jacqueline Jeruss from ⁦University of Michigan⁩ at the ⁦American Surgical⁩ meeting! ⁦ACS Research⁩ helped launch her career and now her daughter, Sydney, is supporting #researcHERS! secure.acsevents.org/site/TR/;jsess… ⁦Sandra Wong⁩

“We’re losing 600,000 Americans every year to this dreaded disease. But, together with the leadership of organizations like Prevent Cancer Foundation & the legislators being honored tonight, we can take a critical step toward ending the scourge of cancer.” - Josh Ofman GRAIL

#OpenAccess in the Oct 1 issue | Older age and smoking were the two most important risk factors associated with the relative and absolute 5-year risk of developing any cancer acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… Alpa Patel Bill Cance ACS Research

Delighted to join our American Cancer Society Cancer Action Network and American Cancer Society partners to move our efforts at earlier cancer detection forward!!

We’re honored to have Galleri Test included in TIME’s Best Inventions of 2022 list! #TIMEBestInventions bit.ly/3DUVGLq

So proud of the depth of science that underpins our transformational multi-cancer early detection test. The translational impact for patients is only beginning!

Great panel discussion today. So important to obtain high quality RWD that is regulatory-grade. Thanks for a superb job moderating, Peter!

New blood tests that screen for risks of cancer and Alzheimer’s provide more information—but what do you do with that information? on.wsj.com/3Aeo4qA

At #ASCO23, GRAIL and OxfordOncology will present results from SYMPLIFY, which show strong performance of multi-cancer early detection testing in people presenting with non-specific symptoms. Learn about the exciting potential of this analysis: bit.ly/3MOOpkZ

Today we announced a new research collaboration with @whitmanwalker and @cancersupporthq that will evaluate multi-cancer early detection screening to increase cancer detection in underserved populations. Learn more: bit.ly/3sp9pZ3

In the latest episode of our podcast #TheCancerSignal, @AICAF_Org CEO Melissa Buffalo delves into why Indigenous communities face disparities in cancer screening and care, and what can be done to address this. 🎙️Listen here: bit.ly/46eTqer

GRAIL has been named on FORTUNE's 2023 #ChangeTheWorld list. This accomplishment is only possible due to the steadfast dedication of our employees, who are working together every day to redefine the status quo of cancer detection. Read more: bit.ly/3ZB1KDu

This past weekend at #AACRDisp23, our team presented data on multi-cancer early detection across races and ethnicities and how it can address socioeconomic disparities in receipt of cancer screening.

We’re initiating a real-world study to evaluate the clinical impact of #MCED screening among Medicare beneficiaries. Learn more here: bit.ly/47IVxrB Please see enclosed video providing a study overview: bit.ly/47FLRhB